The Patent Finder

Qrxpharma Limited

Also on record
Records under this name other than patents Qrxpharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Qrxpharma Limited

PatentTitleStatus Expires Confidence
US 8,012,990Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
Lapsed on the fee record
Ended Sep 6, 2019 · From the USPTO record
Lapsed on the fee recordEnded Sep 6, 2019From the USPTO record
US 7,070,969Plasmin Inhibitors from the Australian Brown Snake Pseudonaja Textilis Textilis
Formerly held
Term ended
Term ended May 7, 2019 · High confidence
Term endedTerm ended May 7, 2019High confidence
US 7,923,453Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
Lapsed on the fee record
Ended Apr 12, 2019 · From the USPTO record
Lapsed on the fee recordEnded Apr 12, 2019From the USPTO record
US 8,933,092Methods and compositions comprising sequential administration opioid receptor agonists
Lapsed on the fee record
Ended Jan 13, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 13, 2019From the USPTO record
US 8,461,171Hybrid opioid compounds and compositions
Lapsed on the fee record
Ended Jun 11, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2017From the USPTO record
US 8,222,267Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
Lapsed on the fee record
Ended Jul 17, 2016 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2016From the USPTO record
US 8,182,837Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
Lapsed on the fee record
Ended May 22, 2016 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited